Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study

Abstract

Memantine treatment was associated with lower axial motor symptom and dyskinesia scores but did not improve gait. These benefits must be confirmed in a broader population of patients.